Tissue-specific resident cells have been identified as a promising population of progenitor cells for cell-based therapies. We describe here the isolation from adult human hearts of tissue nonspecific alkaline phosphatase-positive cells (ALPL+ cells) with mesenchymal stem cell (MSC) characteristics. Samples from 24 adult cadaveric donors were obtained from a valve bank. Mean total ischemia time was 21.5 ± 9.1 hours. The success rate for the isolation of human heart-derived cells by the explant culture technique was 70% for the right auricle (14 of 20 trials) and 33% for the right ventricle (7 of 21 trials). The total auricle-derived cell population (TAD) was used for the purification of ALPL+ cells. TAD and ALPL+ cells expressed markers for MSC and pericytes. TAD cells and ALPL+ cells differentiated into adipocytes, osteoblasts and chondroblasts, and ALPL+ cells expressed markers of these three lineages more strongly than TAD cells, as shown by RT-PCR. This population therefore has a greater potential for differentiation into mesechymal lineages than TAD cells. Both cell populations express some markers of cardiac progenitors, such as GATA4, CD117 and VEGF. ALPL+ cells expressed troponin T and ABCG2, which are also markers of the cardiac lineage. Heart samples from tissue banks could be considered as sources of MSC with putative commitment towards cardiac lineages, even after prolonged ischemia times.
INTRODUCTION
Mesenchymal stem cells (MSC) have been identified as a promising population of progenitor cells for cellbased therapies for the repair of mesenchymal tissue. Under appropriate conditions, they may give rise to various cell types with potential therapeutic applications, including osteoblasts, chondrocytes [1, 2] and cardiomyocytes [3] [4] [5] . Several sources of MSC have been identified, including bone marrow [6] , adipose tissue [7] , umbilical cord blood [8] and heart tissue [9, 10] .
MSC are characterized by the conditions required for their culture, their capacity to differentiate and a panel of various immunophenotyping markers, many of which are also expressed by fibroblasts and other cell types [11] . Several proteins have been identified as markers of the MSC population, for use alone or in combination with other markers. These proteins include mesenchymal stem cell antigen-1 (MSCA-1) [12] . This marker has recently been shown to be identical to tissue nonspecific alkaline phosphatase [13] .
Alkaline phosphatase is a dimeric enzyme catalyzing the hydrolysis of phosphomonoesters, resulting in the release of inorganic phosphate from biomolecules [14] . This enzyme is present in all organisms and in many human tissues. Four isoforms have been described in humans: intestinal, placental, germ cell, and tissue nonspecific alkaline phosphatase [14] . Tissue nonspecific alkaline phosphatase is a phosphatidylinositol-linked plasma membrane glycoprotein, which can therefore be used as a cell marker for immunophenotype characteriza-tion and selection. This protein is a well known marker of embryonic stem cells (ESC) [15, 16] . It is also a marker of neuron progenitor cells in mice [17] . Alkaline phosphatase-positive cells have also been identified as myogenic progenitor cells in human skeletal muscle, in which they were identified as pericytes [18] . Alkaline phosphatase has also been described as a perivascular marker present in MSC from the endometrium [19] . Indeed, the perivascular niche and the pericyte population have now been identified as possible MSC niches, as reviewed [20] .
MSC can be isolated from the human heart, but it remains unclear whether the population of cells enriched in tissue nonspecific alkaline phosphatase has the same characteristics. In this study, we isolated and purified tissue nonspecific alkaline phosphatase-positive cells from heart tissue from cadaveric adult humans provided by a valve bank. We evaluated the characteristics of these cells as possible heart-derived MSC.
MATERIALS AND METHODS

Collection of Human Cardiac Muscle Tissue
Human cardiac muscle tissue was obtained from the human heart valve bank of Charity Hospital of the Brotherhood of Santa Casa de Misericordia de Curitiba, in accordance with the rules of the Oswaldo Cruz Foundation ethics committee (approval number 419/07). This investigation, carried out on human tissues, conformed to the principles outlined in the Helsinki Declaration. Tissue samples from the right auricle and/or right ventricle were collected from cadaveric donors were placed in F12 nutrient mixture supplemented with 2 mM L-glutamine (GibcoTM Invitrogen Corporation, USA), 100 IU/ ml penicillin, and 0.1 mg/ml streptomycin (Sigma, USA). Tissue samples were maintained at 4˚C for no longer than 48 hours before processing.
Isolation and Culture of Human Heart-Derived Cells by Explant Culture
Human heart-derived cells were isolated by explant culture. In brief, heart tissues were rinsed in HBSS (Hanks balanced salt solution) and their mass was determined. We then used scalpels to dissect 500 to 900 mg of tissue into fragments 1 -2 mm 3 in size. We cultured about 100 mg of tissue fragments in each 25 cm 2 culture flask (TPP, Switzerland). The tissue fragments adhered to the culture flasks coated with collagen film (Sigma, USA) after incubation at 37˚C for one hour, in a humidified atmosphere containing 5% carbon dioxide. We then added culture medium. The composition of the maintenance medium was similar to that previously described [18] , consisting of MegaCell™ DMEM (Sigma, USA) supplemented with 5% fetal bovine serum, 2 mM L-glutamine (GibcoTM Invitrogen Corporation, USA), 5 ng/ml basic fibroblast growth factor, 0.1 mM β-mercaptoethanol, 1% non essential amino acids, 100 IU/ml penicillin and 0.1 mg/ml streptomycin (Sigma, USA).
The tissue fragments were cultured for 15 to 30 days, with the replacement of 50% of the medium weekly. After the cells had migrated from the explants, they were harvested by digestion with 0.025% trypsin (GibcoTM Invitrogen Corporation, USA) in 0.02% EDTA (Sigma, USA). Tissue fragments were separated from the cell suspension by passage through a cell strainer with a 40 µm mesh (BD FalconTM, USA). Cells were plated at a density of 0.2 -0.5 × 10 4 cells/cm 2 . Cultured cells from passages 2 to 6 were used for all experiments.
Purification of Alkaline Phosphatase-Positive Cells
For the selection of tissue nonspecific alkaline phosphatase-positive cells (ALPL+), the total auricle-derived cell population (TAD) was incubated with a biotinylated antibody directed against the human tissue nonspecific alkaline phosphatase (R&D Systems, USA). ALPL+ cells were purified with the CellectionTM anti mouse IgG kit (Invitrogen Dynal AS, Norway), in accordance with the manufacturer's instructions. Purified cells were cultured in maintenance medium and subjected to immunophenotyping, gene expression analysis and differentiation assays.
Immunophenotyping by Flow Cytometry
Flow cytometry data were acquired and analyzed as previously described [2] . Briefly, 2 × 10 5 human heartderived cells from passages 2 to 6 were labeled with antibodies against the following human proteins: CD90, CD14, HLA-DR, CD73 and CD140b (BD Pharmingen, San Jose, CA, USA) CD31, CD45, CD34 and CD133/1 (Miltenyi Biotec, Germany), CD105 and CD117 (E-bioscience, USA), tissue nonspecific alkaline phosphatase (R &D Systems, USA), and nestin (BD Pharmingen, USA). For intracellular staining, cells were permeabilized with Fix&Perm reagent (Caltag Laboratories, USA), in accordance with the manufacturer's instructions. Mouse isotype IgG1 antibodies were used as controls (BD PHAR-MINGEN™, USA). About 10,000 labeled cells were acquired with a FACSCalibur flow cytometer (Becton Dickinson, USA) and analyzed with FlowJo software (Flowjo, USA).
Differentiation into Mesenchymal Lineages
TAD and ALPL+ cells were evaluated by inducing their differentiation into adipocytes, osteoblasts and chondroblasts, as previously described [2] . Cells between passages 2 and 6 were incubated with control maintenance medium or differentiation induction medium for 21 days. Cells were then fixed for morphological evaluation by standard staining procedures, with Oil Red for adipogenesis, Von Kossa staining for osteogenesis and toluidine blue staining for chondrogenesis [2] . We also performed RT-qPCR to estimate the level of differentiation-specific mRNA in induced TAD and ALPL+ cells. We analyzed adipogenic differentiation quantitatively, by counting cells from three biological replicates of TAD and ALPL+ cells, with analysis by ImageJ version 1.45d.
Evaluation of Gene Expression by RT-qPCR
Total RNA was obtained with the RNeasy kit (QIA GEN, USA) and samples were treated "in column" with DNAse I (QIAGEN, USA), in accordance with the manufacturer's instructions. Complementary DNA (cDNA) was synthesized from 1 µg of total RNA, with oligo-dT primers (USB Corporation, USA) and a reverse transcriptase kit (IMPROM II, Promega, USA), according to the manufacturers' instructions. PCR was carried out as previously described [2, 25, 23] The primer sets and PCR conditions are listed in Table 1 .
Statistical Analysis
Donor age and total ischemia time are expressed as means ± standard deviation. All other data are expressed as means ± standard error for three or more biological replicates. We used Fisher Exact Test to compare successful cell isolations from auricle or ventricle samples. We used Student's t-test to compare other samples (p < 0.05 considered significant).
RESULTS
Isolation of Human Heart-Derived Cells by Explant Cell Culture
We used the explant cell culture technique to isolate human heart-derived cells from right ventricles or auricles. Samples were obtained from 24 adult cadaveric donors with a mean total ischemia time of 21.5 ± 9.1 hours (range: 2.5 to 41.8 hours). We have not found significant statistical difference when comparing ischemia time and successful and not successful cell isolation (data not shown). The mean age of the donors was 39 years ±12; 54% (n = 13) of the donors were male and 46% (n = 11) were female. After two to four weeks of culture, cells began to migrate from the cultured explants of auricle and ventricle tissues (Figures 1(a)-(b) ). Cells were successfully isolated in 14/20 trials for the right auricle (70%) and 7/21 trials for the right ventricle (33%) with a statistical significance of p < 0.05. Success rates were similar for cultures of explants from male and female donors. However, we did not find statistical significance when comparing isolation success rates from auricle or ventricle samples and donor age classes. We observed a tendency of successful cell isolation in right ventricle samples from younger donors (Figure 1(c) ). Cell isolation success rate from right ventricle samples was 50% for younger donors, but only 17% for older donors. Interestingly, samples from donors between the ages of 31 and 50 gave the highest success rates for cells isolation from right auricle samples. We obtained success rates of 86% for donors aged 31 to 40 years and 100% for donors aged 41 to 50 years. By contrast, success rates were lower (50%) for auricle samples from donors between the ages of 21 and 30 years or between the ages of 51 and 60 years (Figure 1(c) ). In addition, for 17 donors, we evaluated the isolation of human heart-derived cells from both the right ventricle and the right auricle. The success rates for isolation were different for the two explants. We were able to establish cell cultures from 12/17 (70%) auricles and 4/17 (23%) ventricles. Thus, the type of tissue used seems to play an important role in determining the success of human heart-derived cell isolation. These data suggest that the total auricle-derived cell population (TAD) may be a more suitable source of heart-derived cells than the population of cells from the right ventricle.
Auricle-and Ventricle-Derived Cell Cultures are Heterogeneous and Express MSC Markers
We characterized total auricle-derived and total ventricle-derived cell populations by performing RT-PCR and flow cytometry assays. MSC/pericyte markers, such as ALPL, CD44 and alpha smoth muscle actin (ACTA2), were detected in the cell samples by RT-PCR (Figure  2(a) ). We also found markers of myofibroblasts, such as transforming growth factor beta 1 (TGFβ1) and cadherin 11a (Cad11a), and markers for fibroblasts, such as collagen 1a (Col1A) and fibroblast-specific protein 1 (FSP1) (Figure 2(a) ). Thus, cell populations derived from auricle or ventricle explant cultures were heterogeneous and RT-PCR found no difference in the profile of marker expression between them.
However, auricle-derived cell population had higher levels of CD90 and ALPL expression than ventriclederived cells on flow cytometry, whereas amounts of CD105, CD140b and CD117 were similar in both populations (Figure 2(b) ). The auricle-derived cell population may be a more suitable source of heart-derived cells expressing tissue nonspecific alkaline phosphatase than the right ventricle as we found larger amounts of ALPL in auricle samples than in ventricle samples. We therefore used total auricle-derived cells (TAD) for subsequent analyses. 
The ALPL+ Cell Population Can be Purified from Total Auricle-Derived cells (TAD) and Has the Characteristics and Differentiation Potential of MSC
Using magnetic microbeads, we obtained a cell population enriched in cells expressing tissue nonspecific alkaline phosphatase (ALPL+). A single round of purifycation yielded an ALPL+ enriched population of 86.4% ± 6.2% (n = 3), as quantified by flow cytometry (Figure  3(a) ). We then evaluated markers of MSC, pericytes and endothelium cells. We observed no difference in the expression of MSC/perivascular cell markers, such as CD 140b and nestin (Figure 3(b) ).
We analyzed the expression of endothelial markers: CD34 was expressed by less than 15% of cells, Von Willebrand factor (vWF) was expressed by less than 10% of cells and other endothelial markers, such as CD133 and CD31, were not detected at all (Figure 3(c) ). We then evaluated MSC markers. Both TAD and ALPL+ cells expressed positive markers for mesenchymal stem cells, such as CD90, CD105 and CD73 (Figure 3(d) ), and neither of these cell populations expressed negative markers, such as CD45, CD14 and HLA-DR (Figure  3(e) ). Thus, these heart-derived cell populations appear to contain MSC-like cells in accordance with criteria pointed out by Dominici et al. [20] .
Thus, the differentiation of TAD and ALPL+ cells into osteoblasts, adipocytes and chondroblasts was induced. Both populations were able to differentiate along these three lineages, indicating that MSC-like cells are present in both TAD and ALPL+ cells, as shown by phase-contrast microscopy and cytochemistry (Figures 4 (a)-(b) ). The expression of fabp4, collagen 1a and collagen II, lineage-specific markers of adipocytes, osteoblasts and chondroblasts, respectively, was assayed by RT-qPCR (Figure 4(c) ). Fabp4, collagen 1a and collagen II mRNA levels were higher in ALPL+ cultures than in TAD cultures (p < 0.05).
We analyzed adipogenic differentiation, by staining lipid-rich vacuoles with Oil Red O. We observed such differentiation in 48.5% ± 16.1% of TAD cells and 69.6% ± 5.5% of ALPL+ cells, this difference being non signifycant. TAD cells had only a few, very small intracellular lipid droplets (Figure 4(b) ), whereas ALPL+ cells were large and round, with lipid-rich vacuoles in the cytoplasm (Figure 4(b) ). We also evaluated the area, in pixels, covered by lipid-rich vacuoles stained with Oil Red O within an arbitrarily defined region, for three independent donors. The area covered by lipid-rich vacuoles was significantly larger for ALPL+ cells than for TAD (Figure 5) . Thus, the adipocytes differentiated in ALPL+ cells were more mature than those in TAD cultures. 
Expression of Cardiac Markers
We evaluated the expression of cardiac markers (Figure 6) . Both the TAD and ALPL+ cell populations expressed GATA4, an early cardiomyogenic marker [26] , and CD117, a cardiac progenitor marker [27] . We also observed the expression of VEGF, an endothelial growth factor [28] . ALPL+ cells also expressed another marker of cardiac-resident stem cells: the side population marker ABCG2 [29, 30] . In addition, these cells expressed cardiac troponin T, another cardiac lineage marker.
DISCUSSION
studied were isolated from animal models [31, 32] or from fresh material obtained during biopsies on donors with cardiac diseases [27, 33] . MSC have also previously been isolated from human heart tissues taken from terminal heart failure patients undergoing heart transplantation [9] . However, heart failure may interfere with the homeostasis of the organ, thus affecting the putative cardiac progenitor population, as demonstrated by Gálvez et al. [34] . Taking these facts into account, we decided to investigate whether MSC expressing the ALPL marker could be isolated from human heart samples with no heart condition related to death cause.
The aim of this study was to isolate ALPL+ cells from human heart samples from a valve bank. We showed that a heart-derived cell population enriched in cells expressing tissue nonspecific alkaline phosphatase had mesenchymal stem cells characteristics such as plastic adherence, antigenic profile and the potential to differentiate into mesenchymal lineages [20] . We also showed that heart-derived ALPL+ cells expressed a repertoire of cardiac markers.
Alkaline phosphatase has been shown to be a marker for MSC in bone marrow, embryonic stem cells, neuronal progenitor cells, myogenic pericytes in human skeletal muscle and endometrial MSC-like cells [12, 13, 15, [17] [18] [19] . We investigated ALPL+ cells in human hearts.
In valve banks, hearts are processed for valve extraction and muscle tissue is actually discarded. We evaluated samples with a mean total ischemia time of 21.5 ± 9.1 hours with up to 48 hours elapsing before cell isolation. In most previous studies, the cardiac progenitor cells We were able to isolate MSC, by the explant cell culture technique, from the right auricles of human cadaveric donors. ALPL+ cells may constitute a heart-resident population enriched in MSC, as mRNA levels for mesenchymal lineage markers (osteoblasts, adipocytes and chondroblasts) were higher in ALPL+ cells than in TAD cells induced to differentiate. Indeed, larger numbers of adipocytes were found to be differentiating cells than in TAD cells, and ALPL+ cells also had a higher lipid-rich vesicle content. Thus, the tissue discarded by tissue banks may be evaluated as a source of MSC, even after prolonged ischemia. ALPL expression has been observed in myogenic precursors in skeletal muscle, different from satellite cells [18] . Thus, the ALPL+ cells described here may even resemble the mesoangioblasts described in murine cardiac tissue [32] and in human cardiac tissue from donors with hypertrophic cardiomyopathies [34] . ALPL+ cells may display some commitment to cardiac lineages, as we have shown they express GATA4, a master gene in cardiomyogenic and myocardial differentiation [26] , the cardiac resident stem cell marker CD117 [27] , ABCG2, a marker of the side population, and a well known marker of stem cells and cardiac stem cells [30] , together with the cardiac isoform of troponin T, a marker of the cardiomyocyte lineage.
The expression of these markers may constitute a suitable characteristic for evaluation, as it may be beneficial for cardiac lineage differentiation and for applications in cardiovascular cell therapy. These cells may have several advantages over other adult stem cells, because of their tissue specificity, precommitment and potential autologous use, as suggested for other cardiac progenitor cells [35] . We observed the expression of some cardiac markers in heart-derived MSC in this study. It therefore seems likely that the cardiac niche plays a role in this expression. As pointed out in a review, the stem cell niche is a complex, multifactorial local micro-environment [36] .
The auricle appeared to be the most appropriate source of heart-derived cells. The success rate for cell isolation by explant culture was higher for auricle-derived cells than for ventricle-derived cells. This may reflect differences in the responses to ischemia of the two types of tissue. As previously reported for experimental models, the changes induced by ischemia in atrial muscle cells occur more slower than those induced in ventricular muscle cells, and tissue autolysis is also slower [37, 38] .
By contrast to our isolation of ALPL+ cells from human heart samples, a previous study reported an absence of ALPL detection in MSC from human hearts [39] . These conflicting findings may reflect differences in isolation and culture procedures. Here, we isolated cells by the explant cell culture technique, which may have favored the isolation of ALPL+ cells, and we used a medium described for the isolation of pericytes from human muscle tissue [18] . Cell culture enhances alkaline phosphatase expression in pericytes isolated from mammalian hearts [40] . We may therefore have favored the isolation of human heart pericytes, by selecting tissue nonspecific alkaline phosphatase-expressing cells from an explant cell culture. By contrast, in the other study, cells were obtained by enzymatic digestion of heart samples from donors with heart failure [39] .
The yields of the explant culture method were compatible with successful use in basic research. However, they remained below 100%, and further evaluations are required before this method can be considered for clinical use in autologous therapy. Furthermore, it takes about two to four weeks to isolate the first cells and, as reported here, yield varies with donor age. However, the explant cell culture method is simple, inexpensive and could be easily adapted for cell isolation from material provided by tissue banks, for obtaining heart-derived cells.
In summary, tissue and cell banks now provide hope for improvements in the quality of life of people in need of cell or tissue transplantation. In the future, allogeneic cell banks for cell therapy should be evaluated, as proposed by Pasquinelli et al. [41] . If a heart-derived cell bank could be established, this might make it easier to obtain material for cell-based therapies on the basis of a histocompatibility match. This work provides new insight into possible sources and strategies for obtaining cells and making them available for cell therapy.
